ribometrix

Discovering and developing small molecule drugs that target RNA biology to prevent the production of proteins that drive disease

Ribometrix is a biotechnology company pioneering a unique new class of small molecule therapeutics that directly target and modulate the function of RNA to treat human diseases. Ribometrix leverages its world-leading expertise in three-dimensional structural analysis of RNA and RNA biology to drive its discovery platform for the identification of novel small molecules that modulate the function of RNA and proteins associated with human disease.